Traders Worried That AMAG Pharma Will Fall (AMAG)

Shares of AMAG Pharmaceuticals, Inc. AMAG are higher on the session by 1.95%, currently trading at $20.35. The stock has been moving largely lower over the past two months, off from a recent high near $40.00. Options traders do not see the slide abating anytime soon. A short while ago the October $18.00 put was purchased 1,169 times, on the offer, for $0.50; there was no open interest on the strike. Put volume is now running at 4.07x the daily average with 92% of all puts traded being purchases on the offer. AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and imaging agents to aid in the diagnosis of cancer and cardiovascular disease. For more great research like this, as well as how to play it through options…please visit Benzinga's Options & Volatility Edge and Benzinga's Cash Generator.